Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Reversible cold-induced lens opacity in a hibernator reveals a molecular target for treating cataracts
Hao Yang, Xiyuan Ping, Jiayue Zhou, Hailaiti Ailifeire, Jing Wu, Francisco M. Nadal-Nicolás, Kiyoharu J. Miyagishima, Jing Bao, Yuxin Huang, Yilei Cui, Xin Xing, Shiqiang Wang, Ke Yao, Wei Li, Xingchao Shentu
Hao Yang, Xiyuan Ping, Jiayue Zhou, Hailaiti Ailifeire, Jing Wu, Francisco M. Nadal-Nicolás, Kiyoharu J. Miyagishima, Jing Bao, Yuxin Huang, Yilei Cui, Xin Xing, Shiqiang Wang, Ke Yao, Wei Li, Xingchao Shentu
View: Text | PDF
Research Article Ophthalmology

Reversible cold-induced lens opacity in a hibernator reveals a molecular target for treating cataracts

  • Text
  • PDF
Abstract

Maintaining protein homeostasis (proteostasis) requires precise control of protein folding and degradation. Failure to properly respond to stresses disrupts proteostasis, which is a hallmark of many diseases, including cataracts. Hibernators are natural cold-stress adaptors; however, little is known about how they keep a balanced proteome under conditions of drastic temperature shift. Intriguingly, we identified a reversible lens opacity phenotype in ground squirrels (GSs) associated with their hibernation-rewarming process. To understand this “cataract-reversing” phenomenon, we first established induced lens epithelial cells differentiated from GS-derived induced pluripotent stem cells, which helped us explore the molecular mechanism preventing the accumulation of protein aggregates in GS lenses. We discovered that the ubiquitin-proteasome system (UPS) played a vital role in minimizing the aggregation of the lens protein αA-crystallin (CRYAA) during rewarming. Such function was, for the first time to our knowledge, associated with an E3 ubiquitin ligase, RNF114, which appears to be one of the key mechanisms mediating the turnover and homeostasis of lens proteins. Leveraging this knowledge gained from hibernators, we engineered a deliverable RNF114 complex and successfully reduced lens opacity in rats with cold-induced cataracts and zebrafish with oxidative stress–related cataracts. These data provide new insights into the critical role of the UPS in maintaining proteostasis in cold and possibly other forms of stresses. The newly identified E3 ubiquitin ligase RNF114, related to CRYAA, offers a promising avenue for treating cataracts with protein aggregates.

Authors

Hao Yang, Xiyuan Ping, Jiayue Zhou, Hailaiti Ailifeire, Jing Wu, Francisco M. Nadal-Nicolás, Kiyoharu J. Miyagishima, Jing Bao, Yuxin Huang, Yilei Cui, Xin Xing, Shiqiang Wang, Ke Yao, Wei Li, Xingchao Shentu

×

Figure 3

The UPS promotes the degradation of aggregated crystallin.

Options: View larger image (or click on image) Download as PowerPoint
The UPS promotes the degradation of aggregated crystallin.
(A) GO pathwa...
(A) GO pathway analysis of upregulated proteins in GS and rat lens capsules after cold treatment. Red boxes: ubiquitin-related pathways. (B) Interactions among upregulated ubiquitin enzymes in GS lens capsules post-cold treatment. Gray: E1, blue: E2, red: E3. (C) Immunoblotting to detect expression levels of total ubiquitin protein in GS iLECs and HLECs after 30 minutes of rewarming following 24 and 48 hours of cold treatment. (D) Corresponding statistical graph of C (1-way ANOVA, n = 3 independent experiments). (E) Localization of GFP-tagged mutant crystalline proteins in HLECs and GS iLECs after cold treatment and rewarming. Scale bars: 8 μm. (F) Statistical analysis of fluorescence spot intensity in the live-cell imaging experiment described in E (2-tailed Student’s t tests followed by Holm-Šidák correction, n = 3, 10 cells per experiment). (G and H) Live-cell imaging of GS iLECs showing intracellular localization and relative fluorescence intensity of exogenous αA (Y118D) under conditions 1–5 (1-way ANOVA, n = 3, 5 fields of view per experiment). Scale bar: 20 μm. (I–L) Immunoblotting to detect expression levels of relevant proteins (2-tailed Student’s t test, n = 3 independent experiments). (I) Protein levels of exogenous CRYAA(Y118D) in GS iLECs after 24 hours of low-temperature rewarming. (J) Effect of 3MA+NH4Cl on p62 protein levels. PBS treatment used as control. (K) Effect of MG132 on ERK2 protein levels; DMSO treatment used as control. (L) Protein levels of exogenous CRYAA(Y118D) in GS iLECs after 24 hours of low-temperature rewarming. (M and N) CRYAA (Y118D) localization in GS iLECs after cold treatment and rewarming. Scale bars: 8 μm. Red arrows indicate prominent protein aggregates. Intensity of intracellular fluorescence spots was also quantified (2-tailed Student’s t tests followed by Holm-Šidák correction, n = 3, 10 cells per experiment). (All values are represented as mean ± SD, with *P < 0.05, **P < 0.01, and ***P < 0.001 indicating statistical significance.)

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts